Background The high prevalence of non-specific low back pain and its correlation with the findings in the lumbar multifidus muscles (electromyography activity, morphology and thickness) and good ...
Low back pain represents a leading cause of disability worldwide, with musculoskeletal dysfunction and altered motor control often implicated in its onset and persistence. Central to understanding and ...
The Food and Drug Administration (FDA) has approved ReActiv8® (Mainstay Medical), an implantable neurostimulation system, for the treatment of intractable chronic low back pain. Specifically, the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results